Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 27:S15-S35, 2004
© 2004 by the American Diabetes Association, Inc.


Position Statements
Original Article

Standards of Medical Care in Diabetes

American Diabetes Association

Abbreviations: ABI, ankle-brachial index • ARB, angiotensin receptor blocker • CAD, coronary artery disease • CHD, coronary heart disease • CSII, continuous subcutaneous insulin injection • CVD, cardiovascular disease • FPG, fasting plasma glucose • GCT, glucose challenge test • DCCB, dihydropyridine calcium channel blocker • DCCT, Diabetes Control and Complications Trial • DKA, diabetic ketoacidosis • DRS, Diabetic Retinopathy Study • ECG, electrocardiogram • eGFR, estimated GFR • ESRD, end-stage renal disease • ETDRS, Early Treatment Diabetic Retinopathy Study • GDM, gestational diabetes mellitus • GFR, glomerular filtration rate • HRC, high-risk characteristic • IFG, impaired fasting glucose • IGT, impaired glucose tolerance • MNT, medical nutrition therapy • NPDR, nonproliferative diabetic retinopathy • OGTT, oral glucose tolerance test • PAD, peripheral arterial disease • PDR, proliferative diabetic retinopathy • PPG, postprandidial plasma glucose • SMBG, self-monitoring of blood glucose • UKPDS, U.K. Prospective Diabetes Study

The first 300 words of the full text of this article appear below.


    INTRODUCTION
 
Diabetes is a chronic illness that requires continuing medical care and patient self-management education to prevent acute complications and to reduce the risk of long-term complications. Diabetes care is complex and requires that many issues, beyond glycemic control, be addressed. A large body of evidence exists that supports a range of interventions to improve diabetes outcomes.

These standards of care are intended to provide clinicians, patients, researchers, payors, and other interested persons with the components of diabetes care, treatment goals, and tools to evaluate the quality of care. While individual preferences, comorbidities, and other patient factors may require modification of goals, targets that are desirable for most patients with diabetes are provided. These standards are not intended to preclude more extensive evaluation and management of the patient by other specialists as needed. For more detailed information, refer to Bode (Ed.): Medical Management of Type 1 Diabetes (1), Zimmerman (Ed.): Medical Management of Type 2 Diabetes (2), and Klingensmith (Ed): Intensive Diabetes Management (3).

The recommendations included are diagnostic and therapeutic actions that are known or believed to favorably affect health outcomes of patients with diabetes. A grading system (Table 1), developed by the American Diabetes Association (ADA) and modeled after existing methods, was utilized to clarify and codify the evidence that forms the basis for the recommendations. The level of evidence that supports each recommendation is listed after each recommendation using the letters A, B, C, or E.


View this table:
[in this window]
[in a new window]
 
Table 1— ADA evidence grading system for clinical practice recommendations

 

    CLASSIFICATION, DIAGNOSIS, AND SCREENING
 
Classification
In 1997, the ADA issued new diagnostic and classification criteria (4); in 2003, modifications were made regarding the diagnosis of impaired fasting glucose (IFG) (5). The classification of diabetes includes four clinical classes: Diagnosis
Screening
Detection and diagnosis of GDM
Recommendations

    INITIAL EVALUATION
 

    MANAGEMENT
 
Glycemic control
Referral for diabetes management
Intercurrent illness
Recommendations

    ASSESSMENT OF GLYCEMIC CONTROL
 
SMBG
Recommendations
A1C
Recommendations

    MNT
 
Recommendations

    PHYSICAL ACTIVITY
 
Recommendations

    PREVENTION AND MANAGEMENT OF DIABETES COMPLICATIONS
 
I. CVD: management of risk factors and screening for coronary artery disease
A. Blood pressure control
Recommendations
B. Lipid management
Recommendations
C. Anti-platelet agents in diabetes
Recommendation
D. Smoking cessation
Recommendations
E. CHD screening and treatment
Recommendations
II. Nephropathy screening and treatment
Recommendations
General recommendations
Screening
Treatment
III. Diabetic retinopathy screening and treatment
Recommendations
General recommendations
Screening
Treatment
IV. Foot care
Recommendations

    PREVENTIVE CARE
 
I. Preconception care
Recommendations
II. Immunization
Recommendations

    SPECIAL CONSIDERATIONS
 
I. Care of older adults with diabetes
II. Children and adolescents
Strategies for improving diabetes care

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JAMAHome page
J. S. Ross, E. H. Bradley, and S. H. Busch
Use of health care services by lower-income and higher-income uninsured adults.
JAMA, May 3, 2006; 295(17): 2027 - 2036.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. C. Durso
Using clinical guidelines designed for older adults with diabetes mellitus and complex health status.
JAMA, April 26, 2006; 295(16): 1935 - 1940.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J. Rosenstock, B. Zinman, L. J. Murphy, S. C. Clement, P. Moore, C. K. Bowering, R. Hendler, S.-P. Lan, and W. T. Cefalu
Inhaled Insulin Improves Glycemic Control When Substituted for or Added to Oral Combination Therapy in Type 2 Diabetes: A Randomized, Controlled Trial
Ann Intern Med, October 18, 2005; 143(8): 549 - 558.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
E. Selvin, S. Marinopoulos, G. Berkenblit, T. Rami, F. L. Brancati, N. R. Powe, and S. H. Golden
Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus
Ann Intern Med, September 21, 2004; 141(6): 421 - 431.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
D. M. Nathan and W. H. Herman
Screening for Diabetes: Can We Afford Not To Screen?
Ann Intern Med, May 4, 2004; 140(9): 756 - 758.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2004 by the American Diabetes Association.